Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
Master of Finance
Baccalauréat
(1986 - 1993)
2022
2022
2020
2020
2021
Open Stent Solution (OSS) develops the first longitudinally expandable valved stent, paving the way for the new open stent concept for the treatment of heart valve disease.
2021 - 2022
2021 - 2022
2020 - 2022
2020 - 2022
In VCLife topics dealing with early sciences, funding, entrepreneurs, Big Pharmas, M&A, patients care will be openly debate. There will be an important footprint on Therapeutics but Med Tech, Diagnostic and the revolution of Digital Health will also feed the posts. Discussion and feed back are always welcome thus do not hesitate to comment or email me.
2015 - 2022
2015 - 2022
CLOSINVIT est une plateforme unique d'invitations pour des spectacles vivants. Cinéma, théâtre, spectacles humoristiques, nouvelles comédies, nouvelles production à découvrir. CLOSINVIT: INVITEZ-VOUS ! www.closinvit.com
2011 - 2022
2011 - 2022
Billetterie en ligne et promotion de spectacles vivants avec près de 60'000 membres. Rejoignez Closevent sur: http://www.closevent.com/mon_compte-10.html
2007 - 2010
2007 - 2010
Evaluation of early stage/ spin off investments in Life Science (Biopharma and device companies). Sourcing, diligence of > 400 opportunities and completion of 2 US deals.
2006 - 2007
2006 - 2007
In charge of the Marketing strategy and activities of the company portfolio in Europe (Monoclonal Antibodies in Inflammation, Solid tumor, multiple myeloma)
2002 - 2006
2002 - 2006
Co-leading EU licensing/ acquisition projects in METABOLISM (diabetes/ obesity) and VIROLOGY (HIV, HBV, HCV, vaccines).